Biological: Botulinum toxin type A: chronic pain clinical trials
Registry records that list "Biological: Botulinum toxin type A" as an intervention. Being studied does not mean an intervention works or is approved.
0
Trials with Canadian sites
0
Recruiting in Canada
4
Registry records in total
Trials in Canada
No trial with a Canadian site lists this intervention in this snapshot.
Trials worldwide (outside Canada)
4 trials, 0 recruiting or not yet recruiting. Recruiting first.
| Phase | Countries | ||||
|---|---|---|---|---|---|
| Dysport in Post-Surgical Neuralgia NCT03663101 | Completed | Phase 2 | United Kingdom | Ipsen | 2018-10-30 |
| Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Chronic Migraine in Korea NCT01976611 | Completed | South Korea | Allergan | 2012-06 | |
| Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy? NCT00455637 | Terminated | Phase 2 | United Kingdom | Ipsen | 2007-03 |
| Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain NCT00246155 | Completed | Phase 3 | South Korea | Ipsen | 2005-01 |
Conditions studied with this intervention
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.